Real World Evidence (RWE)
Real World Evidence (RWE) studies and research services
Medaffcon uniquely combines medical and health economic perspectives with modern data solutions. Our high-quality services result from extensive content and process expertise and a strong cooperation network in the pharmaceutical industry, healthcare, the academy, and the research community.
Real World Evidence (RWE) studies and research services
Health economic modelling to support decision-making
Medicinal products' pricing and reimbursement processes
Expert resources for your company's needs
Large data entities presented in practical, interactive tools
Risk-sharing agreements' planning and contract negotiations
Tailor-made training programs based on your needs
In healthcare, there is a vast amount of data being generated and processed. Sometimes, its utilization is cumbersome because the data is scattered, and its analysis requires a lot of preprocessing.
My list of publications includes over 20 peer-reviewed scientific articles. One of them is a special one because the Finnish Current Care Guidelines mention it for heart failure. This blog discusses the impact of research by Medaffcon on treatment practices.
We are remodeling the Health from Data Blog – The new name is "Health Data Site by Medaffcon", and it will have a fragment in our Newsletter
Sr. Scientific Advisor
Mariann joined Medaffcon’s team in 2016 after finishing her PhD. The transition to real world evidence (RWE) research was a natural continuum to her previous research career. Through RWE studies, she has had the privilege to gain a broad insight into working with different stakeholders within the healthcare field. The vast proportion of her days goes towards interacting with clients, planning and performing RWE studies, and supporting Medaffcon’s RWE team. Subjects that keep her work interesting are the vast variability of customers and projects, problem-solving, and interacting with people.
“The number of RWE studies has increased since stakeholders within the healthcare industry have an increasing demand for knowledge-based decision making tools that need to be fulfilled. The future, therefore, has an ever-increasing emphasis on RWE”.
Sr. Health Economist
Market Access Lead
MSc (Health Economics)
Heini joined Medaffcon’s Market Access team in the spring of 2018. Heini holds master’s degree in health and social sciences, majoring in Health Economics. Prior to moving into the field of pharmacoeconomics, Heini has worked as an entrepreneur in the health and sport industry. At Medaffcon, Heini works as Market Access Lead with various market access processes and health technology assessments.
Heini has a wide range of expertise in the price and reimbursement processes and health technology assessments in multiple therapy areas. Heini is interested in the possibilities to turn data into understandable information to support healthcare decision-making and thus increase the patient’s well-being. Together with her team and clients she strives to facilitate the provision of bespoke solutions for customers’ pricing and market access needs.
Data Analysis Lead
Iiro joined Medaffcon in March 2017 as a Biostatistician. For the preceding four years, he has worked as a research assistant in an academic study group, analyzing clinical and genetic patient data. Iiro holds a Master of Science degree in Technology in Bioinformation Technology.
Iiro’s strengths include his strong expertise in statistics and data-analysis, hands-on experience in working with sensitive patient data, and strong interdisciplinary communication skills with experts from various fields. In the field, he is particularly interested in the large data amounts made available with the revolution of technology and how the information received such data can potentially be utilized to draw concrete conclusions, both in order to understand the nature of diseases and to advance the goals of the pharmaceutical industry and patient treatment.
“Machine learning and AI-based solutions will have a major impact on the healthcare sector now and in the future. However, effectively utilizing the already collected and available health-data will have a higher importance in order to improve health-care”.
Sr. Scientific Project Manager
Medical Affairs Lead
MSc (Food Science), MBA
Kristiina joined Medaffcon as a Business development manager in 2012. She started her career in a CRO, after which she worked in scientific advisor and line manager positions in two large pharmaceutical organizations, now reaching already 15 years in the business. Kristiina holds master’s degrees in both Nature Sciences and Business (Henley MBA).
At Medaffcon, nowadays as a Medical Affairs team lead, Kristiina leverages her long experience from various stakeholders in the business and her vast therapeutic area expertise in close collaboration with her team to the benefit of customer assignments. When asking what the best part of this work is, she refers to the fast change and the continuous strive for the better, for all of us, as health care service utilizers. ”Every year, I feel that never before have we been working on such vast and important topics and yet, next year the feeling is the same again”.
Jarmo joined Medaffcon as a partner and CEO in 2010, having previously worked in various expert and management positions in pharma companies for eight years. Jarmo has a degree in economics and before entering the pharmaceutical industry, he held an office at the Turku School of Economics and also worked as a research fellow at Turku University Hospital.
Jarmo has strong expertise in new health technology innovations and how the demands and expectations of authorities, markets and customers are matched. He also brings to Medaffcon extensive experience in health economics and its applications in research and commercialization, as well as a broad understanding of the ever-changing operating environment.
“From an access point of view, the Finnish health technology market is constantly becoming more demanding and therefore also more attractive from my point of view. On the other hand, increasing demands to demonstrate the effectiveness and cost-effectiveness of healthcare are broadening the scope and opportunities for Medaffcon to be involved in the development of healthcare as a whole”.